Skip to content
Clinical Trials – home

Hestia Duran I Reynals

Verifiedinfo

Spain Avinguda de la Granvia de l'hospitalet 199-203, 08908 L'hospitalet De Llobregat, Spain

  • 8 trials recruiting
  • Colorectal cancer metastatic · Plasma cell myeloma · Lung neoplasm malignant
  • Adult patients

About Specializations

Hestia Duran I Reynals in L'hospitalet De Llobregat, Spain specialises in clinical trials of conditions such as Colorectal cancer metastatic, Plasma cell myeloma, Lung neoplasm malignant, Small cell lung cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiology and Rare Diseases

The medical center is at the forefront of research in cardiology and rare diseases, with a particular focus on Light Chain (AL) Amyloidosis. This condition is characterized by the deposition of amyloid proteins in organs and tissues, leading to organ dysfunction.

  • Light Chain (AL) Amyloidosis
  • Advanced Heart Failure
  • Cardiac Amyloidosis

Through its innovative research, the center is contributing to the development of new therapeutic strategies aimed at improving patient outcomes and quality of life. The ongoing studies are pivotal in understanding the pathophysiology of amyloidosis and enhancing the efficacy of treatment protocols.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Avinguda de la Granvia de l'hospitalet 199-20308908 L'hospitalet De LlobregatSpain
Recruiting now
8 trials
Conditions studied
22
Partner status
Verified

More sites in L'hospitalet De LlobregatSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

19 clinical trials

Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Healthcare KGaA
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tarlatamab
  • Sponsor:ETOP IBCSG Partners Foundation
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pirtobrutinib
  • Sponsor:Fundacion Geltamo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Gruppo Oncologico Dell'Italia Meridionale
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Fundacion PETHEMA
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Consorzio Oncotech
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Paclitaxel
  • Sponsor:Institut Gustave Roussy
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cedazuridine
  • Sponsor:Taiho Oncology Inc.

Glioblastoma

Not recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Novocure GmbH
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Grupo Espanol De Tumores Neuroendocrinos
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.